Quadrant Capital Group LLC Buys 2,017 Shares of Cigna Group $CI

Quadrant Capital Group LLC boosted its position in shares of Cigna Group (NYSE:CI) by 34.7% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 7,834 shares of the health services provider’s stock after acquiring an additional 2,017 shares during the period. Quadrant Capital Group LLC’s holdings in Cigna Group were worth $2,258,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. Harbor Capital Advisors Inc. lifted its position in shares of Cigna Group by 119.5% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider’s stock worth $26,000 after acquiring an additional 49 shares during the period. Collier Financial bought a new stake in shares of Cigna Group during the third quarter valued at approximately $34,000. Traub Capital Management LLC acquired a new position in shares of Cigna Group in the second quarter valued at $48,000. Twin Peaks Wealth Advisors LLC acquired a new position in shares of Cigna Group in the second quarter valued at $52,000. Finally, CNB Bank lifted its position in Cigna Group by 479.4% in the third quarter. CNB Bank now owns 197 shares of the health services provider’s stock worth $57,000 after purchasing an additional 163 shares during the period. Institutional investors and hedge funds own 86.99% of the company’s stock.

Cigna Group Stock Performance

Cigna Group stock opened at $260.79 on Thursday. The firm has a market capitalization of $68.73 billion, a P/E ratio of 11.76, a P/E/G ratio of 0.91 and a beta of 0.27. The stock has a fifty day moving average price of $280.01 and a two-hundred day moving average price of $283.29. Cigna Group has a 52-week low of $239.51 and a 52-week high of $350.00. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.74 and a quick ratio of 0.74.

Cigna Group (NYSE:CI) last issued its earnings results on Thursday, February 5th. The health services provider reported $8.08 EPS for the quarter, beating the consensus estimate of $7.88 by $0.20. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The company had revenue of $72.50 billion for the quarter, compared to the consensus estimate of $69.53 billion. During the same quarter in the previous year, the company earned $6.64 EPS. The firm’s revenue for the quarter was up 10.4% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.250- EPS. As a group, analysts anticipate that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, March 19th. Shareholders of record on Thursday, March 5th will be given a $1.56 dividend. This represents a $6.24 dividend on an annualized basis and a yield of 2.4%. This is a boost from Cigna Group’s previous quarterly dividend of $1.51. The ex-dividend date is Thursday, March 5th. Cigna Group’s dividend payout ratio (DPR) is presently 28.13%.

Insider Activity

In other Cigna Group news, insider Everett Neville sold 1,719 shares of the company’s stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $496,636.29. Following the sale, the insider directly owned 5,670 shares of the company’s stock, valued at approximately $1,638,119.70. This represents a 23.26% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Nicole S. Jones sold 2,307 shares of Cigna Group stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $666,515.37. Following the completion of the transaction, the insider owned 32,647 shares of the company’s stock, valued at $9,432,044.77. This trade represents a 6.60% decrease in their position. The disclosure for this sale is available in the SEC filing. 0.70% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on the stock. UBS Group reiterated a “buy” rating and set a $375.00 price target on shares of Cigna Group in a research note on Monday, February 9th. Deutsche Bank Aktiengesellschaft raised their price objective on shares of Cigna Group from $301.00 to $304.00 and gave the stock a “buy” rating in a report on Tuesday, February 10th. Wall Street Zen upgraded shares of Cigna Group from a “hold” rating to a “buy” rating in a research report on Saturday, February 7th. Robert W. Baird lowered their target price on shares of Cigna Group from $372.00 to $315.00 and set an “outperform” rating on the stock in a research note on Thursday, December 11th. Finally, Mizuho set a $325.00 price target on shares of Cigna Group in a research report on Friday, January 9th. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $330.42.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.